Sentinel-lymph-node biopsy for breast cancer: the story is not yet over
- PMID: 19664957
- DOI: 10.1016/S1470-2045(09)70223-2
Sentinel-lymph-node biopsy for breast cancer: the story is not yet over
Comment on
-
Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial.Lancet Oncol. 2009 Sep;10(9):849-54. doi: 10.1016/S1470-2045(09)70194-9. Epub 2009 Aug 5. Lancet Oncol. 2009. PMID: 19664956 Clinical Trial.